Alternative Translation Initiation and Termination of Immunoglobulin (Ig) Folds (AltIg) for the Synthesis of Bifunctional Polypeptides

Case ID:
UA20-180
Invention:

This invention is a novel way to create Alternative Igs (AltIgs). This invention could be used to fuse two proteins together as a single polypeptide by fusing the AltIg end of one protein to the other protein. This would create a different spatial relationship between the proteins than could be achieved if the native Ig was fused in a conventional manner.

Background:
Fusing two proteins into a polypeptide can present engineering challenges when done in a traditional way because often it leaves the functional ends of the proteins in sub-optimal positions. This technology helps overcome this challenge by creating a new spatial relationship between the proteins. This technology can be used as a therapeutic reagent to attack tumor cells, making it a promising cancer treatment.

Applications:

  • Create therapeutic reagents
  • Create recombinant proteins
  • Tumor treatment


Advantages:

  • Efficient use of multi-functional polypeptides
  • Greater utilization of protein function
  • Versatile product with numerous applications
Patent Information:
Contact For More Information:
Garrett Edmunds
Licensing Manager, UAHS-TLA
The University of Arizona
gedmunds@arizona.edu
Lead Inventor(s):
Michael Kuhns
Mark Lee
Deepta Bhattacharya
Keywords: